Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.

Edelweiss Mutual Fund

Edelweiss CRISIL IBX 50:50 Gilt Plus SDL April 2037 Index Fund - Regular Plan - IDCW Option

★★★★★ TopFund est.

TopFund Score (fallback rating)

  • Calculated by: TopFund — used only when no third-party rating exists for this fund
  • Formula: 3-year trailing return percentile within category, adjusted ±1 star for expense ratio
  • Refresh frequency: Whenever TopFund re-syncs this fund's data
  • Limitations: A simplified 2-factor estimate, not equivalent to a rating agency's full analysis

Full rating methodology →

TopFund Score: 51/100 · Average

How this score is calculated

  • Star rating (35%)2/5
  • 3Y CAGR (30%)3.76%
  • Expense ratio (20%)0.18%
  • AUM (15%)₹882 Cr

Not investment advice — an analytical read of public fund data. Methodology →

Edelweiss Mutual Fund · Other · Index Funds

₹12.24

+0.02 (+0.2%)

AUM: ₹882 Cr

NAV updated about 16 hours ago

Plan

Regular

Option

Idcw

Risk

High

Expense Ratio

0.18%

Exit Load

Exit load of 0.10%, if redeemed within 30 days.

Fund Manager

Dhawal Dalal

Inception

Oct 2022

Benchmark

CRISIL IBX 50:50 Gilt Plus SDL Index - April 2037

Sharpe Ratio

-1.46

Std Dev (1Y)

8.41%

Historical Returns (CAGR)

Annualized trailing returns computed from NAV history — past performance only, not a guarantee of future results.

1m

+1.07%

3m

-1.34%

6m

-5.26%

1y

-5.33%

3y

+3.76%

5y

—

10y

—

since inception

+5.03%

TopFund's Take on Edelweiss CRISIL IBX 50:50 Gilt Plus SDL April 2037 Index Fund - Regular Plan - IDCW Option

Edelweiss CRISIL IBX 50:50 Gilt Plus SDL April 2037 Index Fund - Regular Plan - IDCW Option sits in the middle of the pack for Index Funds funds, currently carrying a 2-star rating. Returns have been soft relative to what the category has offered — worth checking if this is a temporary phase or a longer pattern. TopFund's composite Health Score, which weighs rating, 3-year CAGR, expense ratio and fund size, puts it at 51/100.

Cost: At 0.18%, the expense ratio is meaningfully cheaper — about 51% below the Index Funds category average of 0.37% (based on 277 comparable funds). Lower costs compound in your favour over long holding periods.

Risk-adjusted performance: Over the trailing 1-year period, the fund shows a negative Sharpe ratio of -1.46 — over the past year, returns haven't kept pace with the volatility involved, even before accounting for the risk-free rate. Separately, annualised volatility of 8.41% is on the lower side for a Index Funds fund, suggesting a comparatively smoother ride.

Who should invest: This fund is best suited to cost-conscious investors happy to simply match the market rather than try to beat it. The High risk rating means near-term volatility should be expected — this isn't a fund to check daily.

This is an automated, data-driven analysis based on the fund's own metrics and its category peers — not personalized investment advice. Consult a SEBI-registered advisor before investing.

Sector Allocation

Entities 46.05%
Financial 32.32%

Asset Allocation

State Development Loan 51.11%
GOI Securities 46.05%
Cash 1.94%
CBLO 0.90%

Frequently Asked Questions about Edelweiss CRISIL IBX 50:50 Gilt Plus SDL April 2037 Index Fund - Regular Plan - IDCW Option

* Past performance is not indicative of future results. Mutual fund investments are subject to market risks.

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

No comments yet — start the discussion.